Bellicum Pharmaceuticals Inc. (BLCM) dropped -6.3% or -0.23 to $3.42. It is around 618755 shares traded, which is 126.88% compare to the average total volume 487676. The market cap of BLCM is $148.30 million. The year to date change is -69.25%. The 52 week price range is from $3.35 to $10.26. Price of BLCM have changed -2.67% during last week. It have changed -10.98% over last month, -41.13% over last 3 months, -59.40% over last 6 months and -55.97% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BLCM is 4.52. It is 32.16% above current price. The 200-day Moving Averages for BLCM is 6.61. It is 93.27% above current price. The 52-week High is 10.26. It is 200.00% from the current price. The 52-week Low is 3.35. It is -2.05% from current price.
There are some statistics of BLCM. It is has market cap $148.30 million. The share outstanding is 43.36 million. The average volume is 487676. The percent of top 15 Institution holding is 87.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BLCM is -94.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BLCM is -63.57%.